CytoDyn Inc.
CYDY
$0.2265
$0.022511.03%
OTC PK
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.21% | -124.80% | 214.54% | -40.83% | -24.65% |
| Total Depreciation and Amortization | 25.00% | -20.00% | 25.00% | -42.86% | -12.50% |
| Total Amortization of Deferred Charges | -2.65% | -9.60% | 0.00% | -79.58% | 322.07% |
| Total Other Non-Cash Items | -97.16% | -78.92% | -77.58% | 43.68% | 48.34% |
| Change in Net Operating Assets | -153.62% | 103.78% | -401.33% | 138.73% | -5.69% |
| Cash from Operations | -38.20% | -165.92% | 429.70% | 29.34% | 6.67% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -100.00% | 347.89% |
| Total Debt Repaid | -- | 100.00% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 28.40% | 507.71% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | -- | -- | -- |
| Cash from Financing | -- | -100.00% | 180.94% | -5.31% | 455.66% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -37.62% | -123.74% | 743.50% | 37.88% | 170.29% |